Invivyd Inc (IVVD)
2.40
-0.05
(-2.04%)
USD |
NASDAQ |
May 17, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Invivyd Free Cash Flow: -182.33M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -182.33M |
| December 31, 2023 | -173.78M |
| September 30, 2023 | -163.15M |
| June 30, 2023 | -184.42M |
| March 31, 2023 | -204.45M |
| Date | Value |
|---|---|
| December 31, 2022 | -219.99M |
| September 30, 2022 | -245.80M |
| June 30, 2022 | -243.87M |
| March 31, 2022 | -220.04M |
| December 31, 2021 | -184.74M |
Free Cash Flow Range, Past 5 Years
-245.80M
Minimum
Sep 2022
-163.15M
Maximum
Sep 2023
-202.26M
Average
-194.59M
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals Inc | -11.77M |
| Viking Therapeutics Inc | -54.87M |
| Stoke Therapeutics Inc | -85.74M |
| 180 Life Sciences Corp | -10.92M |
| MAIA Biotechnology Inc | -13.30M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -50.21M |
| Cash from Investing (Quarterly) | -0.14M |
| Cash from Financing (Quarterly) | 39.10M |
| Free Cash Flow Per Share (Quarterly) | -0.4355 |
| Free Cash Flow Yield | -68.30% |